Actually there are a lot of positives in the MD&A, the slight drop in production is well within a normal variation so I wouldn't worry about that. The biggest hurdle being faced is the restrictive financing enviroment we are facing, that combined with a low SP makes it a challenge to capitalize on potential acquisitions. Hopefully that will change after Q2 when we will see the effect of recent production increases.
It wouldn't hurt if they tore a page out of ARW's book and did a little more promotion.